Clinical trial

Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2

NCT05833217

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-06-06

PhaseNA

Study timeline

Study start (actual)2023-06-06Date precision: day

Registry last updated2024-12-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Long COVIDunresolved

Insulin Resistanceunresolved

Insulin Sensitivityunresolved

Interventions

Adipose Tissue BiopsyPROCEDURE

Steady State Plasma Glucose (SSPG) TestDIAGNOSTIC_TEST

Sponsors & collaborators

Stanford Universitylead sponsor

Mapped research locations

Palo AltoCalifornia, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05833217 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.